MYND fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. It develops medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on Major Depressive Disorder (“MDD”). The company was founded by Dr. Lyle Oberg and Dr. Wilfred Jefferies on July 6, 2018 and is headquartered in Kelowna, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MYND does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company